Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]

Alexander G. Grønning; Sebastian E. Vonhof; Mahmoud Elbatreek; Anna Hamker; Rebecca D. Szepanowski; Svenja C. Erkelenz; Friederike Langhauser; Javier Egea; Manuela G. Lopez; Jan Baumbach; Christoph Kleinschnitz; Ana I. Casas

doi:10.1016/j.biopha.2026.119881

Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]

Alexander G. Grønning
, Sebastian E. Vonhof
, Mahmoud Elbatreek
, Anna Hamker
, Rebecca D. Szepanowski
, Svenja C. Erkelenz
, Friederike Langhauser
, Javier Egea
, Manuela G. Lopez
, Jan Baumbach
, Christoph Kleinschnitz
, Ana I. Casas^*

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum › Academic

Abstract

The authors regret to inform you that the following section from the Acknowledgements has to be deleted: “A.G.G. was supported by the European Research Council under the European Union’s Horizon 2020 research and innovation programme (Grant agreement no. 101002725) and the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).” And following has to be inserted instead “A.G.G. was supported by the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).” In summary, A.G.G. was only supported by the Novo Nordisk Foundation. The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	119881
Number of pages	1
Journal	Biomedicine & Pharmacotherapy
DOIs	https://doi.org/10.1016/j.biopha.2026.119881
Publication status	E-pub ahead of print - 1 Jan 2026

Access to Document

10.1016/j.biopha.2026.119881

1 Article

Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment
Grønning, A. G., Vonhof, S. E., Elbatreek, M., Hamker, A., Szepanowski, R. D., Erkelenz, S. C., Langhauser, F., Egea, J., Lopez, M. G., Baumbach, J., Kleinschnitz, C. & Casas, A. I., 1 Feb 2025, In: Biomedicine & Pharmacotherapy. 183, 11 p., 117829.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

Grønning, A. G., Vonhof, S. E., Elbatreek, M., Hamker, A., Szepanowski, R. D., Erkelenz, S. C., Langhauser, F., Egea, J., Lopez, M. G., Baumbach, J., Kleinschnitz, C., & Casas, A. I. (2026). Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]. Biomedicine & Pharmacotherapy, Article 119881. Advance online publication. https://doi.org/10.1016/j.biopha.2026.119881

@article{47ff9bc0b7284969a2cd64615d03466a,

title = "Corrigendum to {\textquotedblleft}Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment{\textquotedblright} [Biomed. Pharmacother. 183 (2025) 117829]",

abstract = "The authors regret to inform you that the following section from the Acknowledgements has to be deleted: {\textquotedblleft}A.G.G. was supported by the European Research Council under the European Union{\textquoteright}s Horizon 2020 research and innovation programme (Grant agreement no. 101002725) and the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).{\textquotedblright} And following has to be inserted instead {\textquotedblleft}A.G.G. was supported by the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).{\textquotedblright} In summary, A.G.G. was only supported by the Novo Nordisk Foundation. The authors would like to apologise for any inconvenience caused.",

author = "Gr{\o}nning, \{Alexander G.\} and Vonhof, \{Sebastian E.\} and Mahmoud Elbatreek and Anna Hamker and Szepanowski, \{Rebecca D.\} and Erkelenz, \{Svenja C.\} and Friederike Langhauser and Javier Egea and Lopez, \{Manuela G.\} and Jan Baumbach and Christoph Kleinschnitz and Casas, \{Ana I.\}",

note = "Publisher Copyright: {\textcopyright} 2026 The Authors.",

year = "2026",

month = jan,

day = "1",

doi = "10.1016/j.biopha.2026.119881",

language = "English",

journal = "Biomedicine \& Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

}

Grønning, AG, Vonhof, SE, Elbatreek, M, Hamker, A, Szepanowski, RD, Erkelenz, SC, Langhauser, F, Egea, J, Lopez, MG, Baumbach, J, Kleinschnitz, C & Casas, AI 2026, 'Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]', Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119881

Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]. / Grønning, Alexander G.; Vonhof, Sebastian E.; Elbatreek, Mahmoud et al.
In: Biomedicine & Pharmacotherapy, 01.01.2026.

Research output: Contribution to journal › Erratum / corrigendum › Academic

TY - JOUR

T1 - Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]

AU - Grønning, Alexander G.

AU - Vonhof, Sebastian E.

AU - Elbatreek, Mahmoud

AU - Hamker, Anna

AU - Szepanowski, Rebecca D.

AU - Erkelenz, Svenja C.

AU - Langhauser, Friederike

AU - Egea, Javier

AU - Lopez, Manuela G.

AU - Baumbach, Jan

AU - Kleinschnitz, Christoph

AU - Casas, Ana I.

PY - 2026/1/1

Y1 - 2026/1/1

N2 - The authors regret to inform you that the following section from the Acknowledgements has to be deleted: “A.G.G. was supported by the European Research Council under the European Union’s Horizon 2020 research and innovation programme (Grant agreement no. 101002725) and the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).” And following has to be inserted instead “A.G.G. was supported by the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).” In summary, A.G.G. was only supported by the Novo Nordisk Foundation. The authors would like to apologise for any inconvenience caused.

AB - The authors regret to inform you that the following section from the Acknowledgements has to be deleted: “A.G.G. was supported by the European Research Council under the European Union’s Horizon 2020 research and innovation programme (Grant agreement no. 101002725) and the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).” And following has to be inserted instead “A.G.G. was supported by the Novo Nordisk Foundation (Ref. NNF18CC0034900, NNF23SA0084103)).” In summary, A.G.G. was only supported by the Novo Nordisk Foundation. The authors would like to apologise for any inconvenience caused.

U2 - 10.1016/j.biopha.2026.119881

DO - 10.1016/j.biopha.2026.119881

M3 - Erratum / corrigendum

SN - 0753-3322

JO - Biomedicine & Pharmacotherapy

JF - Biomedicine & Pharmacotherapy

M1 - 119881

ER -

Grønning AG, Vonhof SE, Elbatreek M, Hamker A, Szepanowski RD, Erkelenz SC et al. Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]. Biomedicine & Pharmacotherapy. 2026 Jan 1;119881. Epub 2026 Jan 1. doi: 10.1016/j.biopha.2026.119881

Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829]

Abstract

Access to Document

Fingerprint

Research output

Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment

Cite this